Close

Pre-Open Stock Movers 06/14: (RAPT) (CRSR) (RIOT) Higher; (ATXI) (RIDE) (RACE) Lower (more...)

Go back to Pre-Open Stock Movers 06/14: (RAPT) (CRSR) (RIOT) Higher; (ATXI) (RIDE) (RACE) Lower (more...)

RAPT Therapeutics (RAPT) Adds to Intra-Day Gains Despite Stock Offering; Last Up 23%

June 14, 2021 5:46 PM EDT

RAPT Therapeutics (NASDAQ: RAPT) is adding to its intra-day gains despite announcing a $125 million share stock offering.

Shares are up 22.5% after-hours after gaining 115% intra-day on positive topline results from its randomized placebo-controlled Phase 1b clinical trial of RPT193 as monotherapy in 31 patients with moderate-to-severe atopic dermatitis (AD).

... More

RAPT Therapeutics (RAPT) Announced Proposed Offering of $125M Worth of Shares

June 14, 2021 4:02 PM EDT

RAPT Therapeutics, Inc. (Nasdaq: RAPT) announced that it has commenced an underwritten public offering of $125 million of its common stock. In addition, RAPT expects the underwriters to be granted a 30-day option to purchase up to an additional $18.75 million of its common stock on the same terms and conditions. All of the shares of common stock are being offered by RAPT. The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the... More

Street Largely Bullish on Squarespace (SQSP) on Attractive E-Commerce Services Opportunity and Strong Profitability Growth

June 14, 2021 11:37 AM EDT

Wall Street analysts have started coverage of Squarespace (NYSE: SQSP) with largely positive views. Only two out of ten analysts started the coverage with a Neutral or equivalent ratings while eight - including Citi, JPMorgan, and Goldman Sachs - initiated at Buy or equivalent.

The company made its public debut last month after opening at $48 per share. Prior to that, the company set a reference price of $50.00 per share. Shares plunged on the debut before racing higher to now trade at $60.00 apiece.

Citi analyst Drew Foster started at Buy with a price target of... More